The Relevance of the Dopamine-D1 Receptor in the Cognitive Symptoms of Schizophrenia

被引:0
|
作者
Patricia S Goldman-Rakic
机构
[1] Section of Neurobiology,
[2] Yale University School of Medicine,undefined
来源
Neuropsychopharmacology | 1999年 / 21卷
关键词
Dopamine D; receptors; Prefrontal cortex; Memory; Cognition; Schizophrenia; Cognitive deficits; Antipsychotics;
D O I
暂无
中图分类号
学科分类号
摘要
An understanding of the role of the prefrontal cortex in normal cognitive processes has advanced our comprehension of the pathophysiology underlying the cognitive deficits in schizophrenia. Studies of single-neuron activity in monkeys during performance of delayed-response tasks have confirmed the involvement of the prefrontal cortex in working memory. The “memory fields” of prefrontal neurons are analogous to the receptive fields of visual neurons and the cellular expression of a working memory process that allows mnemonic information to guide behavior. D1-dopamine antagonists produce a dose-dependent effect (U-shaped) on the firing rate of cells with memory fields during delayed-response tasks. Disordered cognitive processes in schizophrenia can be attributed to impairment of function in the prefrontal cortex, as evidenced by hypometabolic activity in the prefrontal cortex and selective impairment in working memory tasks. Advances in our understanding of the role of D1 receptors in the cognitive deficits observed in schizophrenia should provide us with a rational basis for developing alternative antipsychotic treatments and may provide insight into the cellular basis of the disorder.
引用
收藏
页码:S170 / S180
相关论文
共 50 条
  • [1] The relevance of the dopamine-D1 receptor in the cognitive symptoms of schizophrenia
    Goldman-Rakic, PS
    NEUROPSYCHOPHARMACOLOGY, 1999, 21 (06) : S170 - S180
  • [2] SCHIZOPHRENIA - DOPAMINE-D1 RECEPTOR SEQUENCE IS NORMAL, BUT HAS DNA POLYMORPHISMS
    OHARA, K
    ULPIAN, C
    SEEMAN, P
    SUNAHARA, RK
    VANTOL, HHM
    NIZNIK, HB
    NEUROPSYCHOPHARMACOLOGY, 1993, 8 (02) : 131 - 135
  • [3] Targeting the dopamine D1 receptor in schizophrenia:: insights for cognitive dysfunction
    Goldman-Rakic, PS
    Castner, SA
    Svensson, TH
    Siever, LJ
    Williams, GV
    PSYCHOPHARMACOLOGY, 2004, 174 (01) : 3 - 16
  • [4] Targeting the dopamine D1 receptor in schizophrenia: insights for cognitive dysfunction
    Patricia S. Goldman-Rakic
    Stacy A. Castner
    Torgny H. Svensson
    Larry J. Siever
    Graham V. Williams
    Psychopharmacology, 2004, 174 : 3 - 16
  • [5] Dopamine D1R Receptor Stimulation as a Mechanistic Pro-cognitive Target for Schizophrenia
    Abi-Dargham, Anissa
    Javitch, Jonathan A.
    Slifstein, Mark
    Anticevic, Alan
    Calkins, Monica E.
    Cho, Youngsun T.
    Fonteneau, Clara
    Gil, Roberto
    Girgis, Ragy
    Gur, Raquel E.
    Gur, Ruben C.
    Grinband, Jack
    Kantrowitz, Joshua
    Kohler, Christian
    Krystal, John
    Murray, John
    Ranganathan, Mohini
    Santamauro, Nicole
    Van Snellenberg, Jared
    Tamayo, Zailyn
    Wolf, Daniel
    Gray, David
    Lieberman, Jeffrey
    SCHIZOPHRENIA BULLETIN, 2022, 48 (01) : 199 - 210
  • [6] Dopamine D4 receptor stimulation contributes to novel object recognition: Relevance to cognitive impairment in schizophrenia
    Miyauchi, Masanori
    Neugebauer, Nichole M.
    Meltzer, Herbert Y.
    JOURNAL OF PSYCHOPHARMACOLOGY, 2017, 31 (04) : 442 - 452
  • [7] A68930 - A POTENT AGONIST SELECTIVE FOR THE DOPAMINE-D1 RECEPTOR
    DENINNO, MP
    SCHOENLEBER, R
    MACKENZIE, R
    BRITTON, DR
    ASIN, KE
    BRIGGS, C
    TRUGMAN, JM
    ACKERMAN, M
    ARTMAN, L
    BEDNARZ, L
    BHATT, R
    CURZON, P
    GOMEZ, E
    KANG, CH
    STITTSWORTH, J
    KEBABIAN, JW
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1991, 199 (02) : 209 - 219
  • [8] RAPID REVERSAL OF DENERVATION SUPERSENSITIVITY OF DOPAMINE-D1 RECEPTORS BY L-DOPA OR A NOVEL DOPAMINE-D1 RECEPTOR AGONIST, A68930
    BRITTON, DR
    KEBABIAN, JW
    CURZON, P
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1991, 200 (01) : 89 - 93
  • [9] NMDA RECEPTOR ANTAGONISTS INHIBIT CATALEPSY INDUCED BY EITHER DOPAMINE-D1 OR DOPAMINE-D2 RECEPTOR ANTAGONISTS
    MOORE, NA
    BLACKMAN, A
    AWERE, S
    LEANDER, JD
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1993, 237 (01) : 1 - 7
  • [10] THE DOPAMINE-D1 RECEPTOR IS INVOLVED IN THE REGULATION OF REM-SLEEP IN THE RAT
    TRAMPUS, M
    FERRI, N
    MONOPOLI, A
    ONGINI, E
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1991, 194 (2-3) : 189 - 194